Achillion Announces Janssen Initiated Phase I Study to Evaluate Effect of Simeprevir and Odalasvir on AL-335 Pharmacokinetics
August 03, 2015 at 04:20 AM EDT
Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN) announced today that Alios Biopharma Inc., part of the Janssen Pharmaceutical Companies ...
